Identification of potential genes/proteins regulated by Tiam1 in colorectal cancer by microarray analysis and proteome analysis

Cell Biology International

Volumn 32, Issue 10, 2008, Pages 1215-1222

  Liu, Li ^a   Wang, Shuang ^a   Zhang, Qingling ^a   Ding, Yanqing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; HMGB1; Microarray; Proteome; Tiam1

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; HIGH MOBILITY GROUP B1 PROTEIN; LIPOCORTIN 4; PHOSPHOGLYCERATE MUTASE; T CELL LYMPHOMA INVASION AND METASTASIS INDUCING PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANNEXIN A4; CELL LINE; COLORECTAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HMGB1 PROTEIN; HUMANS; MICROARRAY ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHOGLYCERATE MUTASE; PROTEOME; RNA INTERFERENCE;

EID: 52949107258     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2008.07.004     Document Type: Article

References (30)

1. Bassi R., Giussani P., Anelli V., Colleoni T., Pedrazzi M., Patrone M., Viani P., Sparatore B., Melloni E., and Riboni L. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neurooncol 87 (2008) 23-33
2. Evans A., Lennard T.W., and Davies B.R. High-mobility group protein 1(Y): metastasis-associated or metastasis-inducing?. J Surg Oncol 88 (2004) 86-99
3. Habets G.G., Scholtes E.H., Zuydgeest D., van der Kammen R.A., Stam J.C., Berns A., and Collard J.G. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 77 (1994) 537-549
4. Hou M., Tan L., Wang X., and Zhu Y.S. Antisense Tiam1 down-regulates the invasiveness of 95D cells in vitro. Acta Biochim Biophys Sin (Shanghai) 36 (2004) 537-540
5. Huang Z.X., Sun Q., Ding Y.Q., and Yao K.T. [Mining microarray gene expression data of metastatic colorectal cancer by literature profiling]. Di Yi Jun Yi Da Xue Xue Bao 23 (2003) 1195-1197
6. Huttunen H.J., Fages C., and Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 274 (1999) 19919-19924
7. Kuniyasu H., Chihara Y., and Kondo H. Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer 104 (2003) 722-727
8. Kuniyasu H., Chihara Y., and Takahashi T. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 10 (2003) 445-448
9. Kuniyasu H., Sasaki T., Sasahira T., Ohmori H., and Takahashi T. Depletion of tumor-infiltrating macrophages is associated with amphoterin expression in colon cancer. Pathobiology 71 (2004) 129-136
10. Liu L., Wu D.H., and Ding Y.Q. Tiam1 gene expression and its significance in colorectal carcinoma. World J Gastroenterol 11 (2005) 705-707
11. Liu L., Xu A.G., Yang Y.F., and Ding Y.Q. [Tiam1 expression correlates with the biological behavior of human colorectal carcinoma cells]. Zhonghua Bing Li Xue Za Zhi 34 (2005) 664-668
12. Liu L., Zhang Q., Zhang Y., Wang S., and Ding Y. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 8 (2006) 917-924
13. Liu L., Zhao L., Zhang Y., Zhang Q., and Ding Y. Proteomic analysis of Tiam1-mediated metastasis in colorectal cancer. Cell Biol Int 31 (2007) 805-814
14. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
15. Lotze M.T., and DeMarco R.A. Dealing with death: HMGB1 as a novel target for cancer therapy. Curr Opin Invest Drugs 4 (2003) 1405-1409
16. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 5 (2005) 331-342
17. Malliri A., van der Kammen R.A., Clark K., van der Valk M., Michiels F., and Collard J.G. Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417 (2002) 867-871
18. Masunaga R., Kohno H., Dhar D.K., Ohno S., Shibakita M., Kinugasa S., Yoshimura H., Tachibana M., Kubota H., and Nagasue N. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin Cancer Res 6 (2000) 4064-4068
19. Minard M.E., Kim L.S., Price J.E., and Gallick G.E. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat 84 (2004) 21-32
20. Minard M.E., Herynk M.H., Collard J.G., and Gallick G.E. The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse model. Oncogene 24 (2005) 2568-2573
21. Minard M.E., Ellis L.M., and Gallick G.E. Tiam1 regulates cell adhesion, migration and apoptosis in colon tumor cells. Clin Exp Metastasis 23 (2006) 301-313
22. Oue N., Aung P.P., Mitani Y., Kuniyasu H., Nakayama H., and Yasui W. Genes involved in invasion and metastasis of gastric cancer identified by array-based hybridization and serial analysis of gene expression. Oncology 69 Suppl.1 (2005) 17-22
23. Riuzzi F., Sorci G., and Donato R. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo. J Biol Chem 281 (2006) 8242-8253
24. Sasahira T., Akama Y., Fujii K., and Kuniyasu H. Expression of receptor for advanced glycation end products and HMGB1/amphoterin in colorectal adenomas. Virchows Arch 446 (2005) 411-415
25. Sorci G., Riuzzi F., Arcuri C., Giambanco I., and Donato R. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol 24 (2004) 4880-4894
26. Soumaoro L.T., Uetake H., Higuchi T., Takagi Y., Enomoto M., and Sugihara K. Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer. Clin Cancer Res 10 (2004) 8465-8471
27. Sun Q., Ding Y.Q., Gao X.Q., Yan S., and Han J.X. [Development and application of cDNA microarray of tumor metastasis-associated genes]. Di Yi Jun Yi Da Xue Xue Bao 22 (2002) 1070-1075
28. Sung J.J., Lau J.Y., Goh K., and Leung W. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol 6 (2005) 871-876
29. Volp K., Brezniceanu M.L., Bosser S., Brabletz T., Kirchner T., Gottel D., Joos S., and Zornig M. Increased expression of high mobility group box 1 (HMGB1) is associated with an elevated level of the antiapoptotic c-IAP2 protein in human colon carcinomas. Gut 55 (2006) 234-242
30. Weng D.S., Ding Y.Q., and Sun Q. [Differences in gene expression profile between high and low metastatic human colorectal cancer cell lines]. Di Yi Jun Yi Da Xue Xue Bao 24 (2004) 256-259